Revance Therapeutics (RVNC) Soars: Stock Up 25.8% - Tale of the Tape


Shutterstock photo

Revance Therapeutics, Inc. ( RVNC ) was a big mover last session, as its shares rose nearly 26% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company as the stock is now trading above the volatile price range of $26.16 to $33.70 in the past one-month timeframe.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn't been in a trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Revance Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include TrovaGene, Inc. ( TROV ), ZIOPHARM Oncology, Inc. ( ZIOP ) and Biogen Idec Inc. ( BIIB ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

REVANCE THERAP (RVNC): Free Stock Analysis Report


ZIOPHARM ONCLGY (ZIOP): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
More Headlines for: BIIB , RVNC , TROV , ZIOP

More from


Equity Research
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by